Cargando…

Donepezil Adherence, Persistence and Time to First Discontinuation in a Three-Year Follow-Up of Older People

BACKGROUND: Donepezil is indicated for the management of mild to moderate dementia, particularly in Alzheimer's disease. Several studies have described low adherence rates with donepezil. AIM: To examine and measure donepezil adherence, persistence and time to first discontinuation in older New...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ndukwe, Henry C., Nishtala, Prasad S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2015
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777950/ https://www.ncbi.nlm.nih.gov/pubmed/26955381 http://dx.doi.org/10.1159/000441894

Ejemplares similares

Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia
por: Park, Kee Hyung, et al.
Publicado: (2021)

The Influence of Patient Characteristics on Anticholinergic Events in Older People
por: Salahudeen, Mohammed Saji, et al.
Publicado: (2016)

Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation
por: Spångeus, Anna, et al.
Publicado: (2020)

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
por: Salahudeen, Mohammed Saji, et al.
Publicado: (2015)

Risk of delirium associated with antimuscarinics in older adults: A case‐time‐control study
por: Nishtala, Prasad S., et al.
Publicado: (2022)

Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature
por: Salahudeen, Mohammed Saji, et al.
Publicado: (2016)

Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics
por: Nishtala, Prasad S., et al.
Publicado: (2019)

Pharmacist-based Donepezil Outpatient Consultation Service to improve medication persistence
por: Watanabe, Norio, et al.
Publicado: (2012)

Analgesic Medicine Utilization in Older People in New Zealand from 2005 to 2013
por: Nishtala, Prasad S., et al.
Publicado: (2015)

Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer’s Disease Patients in Japan: LIFE Study
por: Fukuda, Haruhisa, et al.
Publicado: (2022)

Drug Persistency Patterns for Patients Treated With Rivastigmine or Donepezil in Usual Care Settings
por: Mauskopf, Josephine A., et al.
Publicado: (2005)

Effect of Psychoeducational Intervention on Donepezil Retention Rate and Analysis of Reasons for the Discontinuation in Patients with Alzheimer’s Dementia: A Randomized Study
por: Kamei, Tetsumasa, et al.
Publicado: (2021)

Statin Discontinuation and Cardiovascular Events Among Older People in Denmark
por: Thompson, Wade, et al.
Publicado: (2021)

Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil
por: Tariot, Pierre N., et al.
Publicado: (2022)

Discontinuation of follow-up care for young people with complex chronic conditions: conceptual definitions and operational components
por: Skogby, Sandra, et al.
Publicado: (2021)

Risk of antimicrobial-associated organ injury among the older adults: a systematic review and meta-analysis
por: Chinzowu, Tichawona, et al.
Publicado: (2021)

Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
por: Gajria, Kavita, et al.
Publicado: (2014)

Development of donepezil-induced hypokalemia following treatment of cognitive impairment
por: Kim, Dongryul, et al.
Publicado: (2020)

Application of machine learning approaches in predicting clinical outcomes in older adults – a systematic review and meta-analysis
por: Olender, Robert T., et al.
Publicado: (2023)

Associations of Potentially Inappropriate Medicine Use with Fall-Related Hospitalisations and Primary Care Visits in Older New Zealanders: A Population-Level Study Using the Updated 2012 Beers Criteria
por: Narayan, Sujita W., et al.
Publicado: (2015)

Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases
por: Pooladgar, Parham, et al.
Publicado: (2022)

Utility of Big Data to Explore Medication Adherence in Māori and Non-Māori Community-Dwelling Older Adults with Heart Failure in Aotearoa New Zealand: A Cross-sectional Study
por: Hikaka, Joanna, et al.
Publicado: (2023)

886. The Impact of the COVID-19 Pandemic on Clinical Follow-Up, Monitoring and Regimen Discontinuation for People Living with HIV in the US
por: Pierone, Gerald, et al.
Publicado: (2021)

Antibacterial‐associated acute kidney injury among older adults: A post‐marketing surveillance study using the FDA adverse events reporting system
por: Chinzowu, Tichawona, et al.
Publicado: (2022)

Hydroxychloroquine concentrations persist after drug discontinuation
Publicado: (2022)

Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil
por: Persson, Cecilia M, et al.
Publicado: (2009)

Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012)

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022)

Durable recovery from amblyopia with donepezil
por: Wu, Carolyn, et al.
Publicado: (2023)

Health outcomes and adherence to a healthy lifestyle after a multimodal intervention in people with multiple sclerosis: Three year follow-up
por: Marck, Claudia H., et al.
Publicado: (2018)

Discontinuity of Cardiac Follow‐Up in Young People With Congenital Heart Disease Transitioning to Adulthood: A Systematic Review and Meta‐Analysis
por: Moons, Philip, et al.
Publicado: (2021)

Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Bergler, Ulrich, et al.
Publicado: (2021)

Persistence of Symptoms in Veterans of the First Gulf War: 5-Year Follow-up
por: Ozakinci, Gozde, et al.
Publicado: (2006)

Residual Effect of Texting to Promote Medication Adherence for Villagers with Schizophrenia in China: 18-Month Follow-up Survey After the Randomized Controlled Trial Discontinuation
por: Cai, Yiyuan, et al.
Publicado: (2022)

Anterior thalamic deep brain stimulation in epilepsy and persistent psychiatric side effects following discontinuation
por: Doležalová, Irena, et al.
Publicado: (2019)

Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil
por: Ortner, Marion, et al.
Publicado: (2020)

Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women
por: Ha, J., et al.
Publicado: (2022)

Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease
por: Wawruch, Martin, et al.
Publicado: (2021)

Role of Donepezil in Autism: Its Conduciveness in Psychopharmacotherapy
por: Srivastava, Rohit Kant, et al.
Publicado: (2011)

Neuroprotective effects of donepezil against cholinergic depletion
por: Cutuli, Debora, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_clfroo0b2ig6u5k64vrag1ckmo